These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21420512)

  • 1. Identification of a novel and potent inhibitor of phospholipase A(2) in a medicinal plant: crystal structure at 1.93Å and Surface Plasmon Resonance analysis of phospholipase A(2) complexed with berberine.
    Chandra DN; Prasanth GK; Singh N; Kumar S; Jithesh O; Sadasivan C; Sharma S; Singh TP; Haridas M
    Biochim Biophys Acta; 2011 May; 1814(5):657-63. PubMed ID: 21420512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure.
    Chandra V; Jasti J; Kaur P; Srinivasan A; Betzel Ch; Singh TP
    Biochemistry; 2002 Sep; 41(36):10914-9. PubMed ID: 12206661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
    Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of specific peptide inhibitors of phospholipase A2: structure of a complex formed between Russell's viper phospholipase A2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS).
    Chandra V; Jasti J; Kaur P; Dey S; Srinivasan A; Betzel Ch; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1813-9. PubMed ID: 12351825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.
    Singh N; Jabeen T; Somvanshi RK; Sharma S; Dey S; Singh TP
    Biochemistry; 2004 Nov; 43(46):14577-83. PubMed ID: 15544328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverted binding due to a minor structural change in berberine enhances its phospholipase A2 inhibitory effect.
    Chandra DN; Abhilash J; Prasanth GK; Sabu A; Sadasivan C; Haridas M
    Int J Biol Macromol; 2012 Apr; 50(3):578-85. PubMed ID: 22305795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of a complex formed between a snake venom phospholipase A(2) and a potent peptide inhibitor Phe-Leu-Ser-Tyr-Lys at 1.8 A resolution.
    Chandra V; Jasti J; Kaur P; Dey S; Perbandt M; Srinivasan A; Betzel Ch; Singh TP
    J Biol Chem; 2002 Oct; 277(43):41079-85. PubMed ID: 12186870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis of substituted benzoylacrylic acids as potential antagonists of phospholipase A2].
    Nuhn P; Herrmann A; Radman M
    Pharmazie; 1999 Feb; 54(2):93-8. PubMed ID: 10084154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third calcium ion found in an inhibitor-bound phospholipase A2.
    Sekar K; Gayathri D; Velmurugan D; Jeyakanthan J; Yamane T; Poi MJ; Tsai MD
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):392-7. PubMed ID: 16552140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution.
    Chandra V; Jasti J; Kaur P; Betzel Ch; Srinivasan A; Singh TP
    J Mol Biol; 2002 Jul; 320(2):215-22. PubMed ID: 12079380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous inhibition of anti-coagulation and inflammation: crystal structure of phospholipase A2 complexed with indomethacin at 1.4 A resolution reveals the presence of the new common ligand-binding site.
    Singh N; Kumar RP; Kumar S; Sharma S; Mir R; Kaur P; Srinivasan A; Singh TP
    J Mol Recognit; 2009; 22(6):437-45. PubMed ID: 19462410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asp49 phospholipase A(2)-elaidoylamide complex: a new mode of inhibition.
    Georgieva DN; Rypniewski W; Gabdoulkhakov A; Genov N; Betzel C
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1314-21. PubMed ID: 15194511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the complex of the secretory phospholipase A2 from Daboia russelli pulchella with an endogenic indole derivative, 2-carbamoylmethyl-5-propyl-octahydro-indol-7-yl-acetic acid at 1.8 A resolution.
    Balasubramanya R; Chandra V; Kaur P; Singh TP
    Biochim Biophys Acta; 2005 Sep; 1752(2):177-85. PubMed ID: 16122995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray structure at 1.76 A resolution of a polypeptide phospholipase A2 inhibitor.
    Devedjiev Y; Popov A; Atanasov B; Bartunik HD
    J Mol Biol; 1997 Feb; 266(1):160-72. PubMed ID: 9054978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution X-ray crystallography reveals precise binding interactions between human nonpancreatic secreted phospholipase A2 and a highly potent inhibitor (FPL67047XX).
    Cha SS; Lee D; Adams J; Kurdyla JT; Jones CS; Marshall LA; Bolognese B; Abdel-Meguid SS; Oh BH
    J Med Chem; 1996 Sep; 39(20):3878-81. PubMed ID: 8831753
    [No Abstract]   [Full Text] [Related]  

  • 16. Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032.
    Kitadokoro K; Hagishita S; Sato T; Ohtani M; Miki K
    J Biochem; 1998 Apr; 123(4):619-23. PubMed ID: 9538252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of specific peptide inhibitors for group I phospholipase A2: structure of a complex formed between phospholipase A2 from Naja naja sagittifera (group I) and a designed peptide inhibitor Val-Ala-Phe-Arg-Ser (VAFRS) at 1.9 A resolution reveals unique features.
    Singh RK; Vikram P; Makker J; Jabeen T; Sharma S; Dey S; Kaur P; Srinivasan A; Singh TP
    Biochemistry; 2003 Oct; 42(40):11701-6. PubMed ID: 14529280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into metal ion binding in phospholipases A2: ultra high-resolution crystal structures of an acidic phospholipase A2 in the Ca2+ free and bound states.
    Murakami MT; Gabdoulkhakov A; Genov N; Cintra AC; Betzel C; Arni RK
    Biochimie; 2006 May; 88(5):543-9. PubMed ID: 16376474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure-guided design of berberine-based novel chitinase inhibitors.
    Chen L; Zhu L; Chen J; Chen W; Qian X; Yang Q
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1937-1943. PubMed ID: 33167737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel pro-coagulant metalloprotease (RVBCMP) possessing alpha-fibrinogenase and tissue haemorrhagic activity from venom of Daboia russelli russelli (Russell's viper): evidence of distinct coagulant and haemorrhagic sites in RVBCMP.
    Mukherjee AK
    Toxicon; 2008 Apr; 51(5):923-33. PubMed ID: 18249434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.